Tag Archives: Take

NICE clears Pierre Fabre's targeted melanoma combo to take on Novartis, Roche drugs

Thanks to new guidance from England’s drug cost watchdog, Novartis and Roche will be getting some fresh targeted melanoma competition from French pharma lab Pierre Fabre.  In guidance published Friday, England’s National Institute for Health and Care Excellence signed off on Pierre Fabre’s combo of Braftovi and Mektovi to treat adult patients with unresectable or metastatic BRAF V600 mutation-positive melanoma.… Read More »

Verily, Walgreens partner to take on chronic conditions

Alphabet subsidiary Verily and Walgreens revealed plans to collaborate with on several fronts to improve care for people with chronic conditions. PIECES OF THE AGREEMENT There are several aspects of the partnership: Walgreens is now the first choice pharmacy partner for Verily The companies will look into emerging technologies, such as sensors and software to… Read More »